yingweiwo

New2

New2

New2 related products

Structure Cat No. Product Name CAS No. Product Description
OTS186935 V31766 OTS186935 2093400-18-9 OTS186935 is a potent inhibitor of protein methyltransferase SUV39H2 with IC50 of 6.49 nM.
OTS186935 triHCl V37760 OTS186935 triHCl 2093401-85-3 OTS186935 triHCl is a potent inhibitor of protein methyltransferase SUV39H2 with IC50 of 6.49 nM.
OTS514 HBr V38925 OTS514 HBr 1338544-87-8 OTS514 HBr is a novel and highly potent inhibitor of the TOPK (T-LAK cell-originated protein kinase) with an IC50 value of 2.6 nM.
OT拮抗剂1 V30471 OT antagonist 1 479080-38-1 OT antagonist 1 (Compound 4) is a potent and specific oxytocin (Oxytocin) antagonist (inhibitor) with Ki of 50 nM.
OV-1, sheep V30911 OV-1, sheep 326855-45-2 OV-1, sheep is an α-helical antimicrobial ovispirin peptide developed from sheep SMAP29 peptide, which can inhibit a variety of drug-resistant strains like mucinous and non-mucinous Pseudomonas aeruginosa.
OVA G4 peptide V32738 OVA G4 peptide 148274-82-2 OVA G4 peptide is a variant of the agonist ovalbumin peptide SIINFEKL (OVA) (257-264).
OVA Peptide (257-264) TFA V33387 OVA Peptide (257-264) TFA 1262751-08-5 OVA Peptide(257-264) TFA is the class I (Kb)-restricted peptide epitope of OVA, which is an octamer peptide that can be developed from ovalbumin presented by the class I MHC molecule H-2Kb.
OVA Peptide 257-264 V33022 OVA Peptide 257-264 138831-86-4 OVA Peptide(257-264) is the class I (Kb)-restricted peptide epitope of OVA, which is an octamer peptide that can be developed from ovalbumin presented by the class I MHC molecule H-2Kb.
OXFBD04 V40635 OXFBD04 2231747-03-6 OXFBD04 is a potent and specific BRD4 inhibitor (antagonist) with IC50 of 166 nM.
P-gp inhibitor 1 V31873 P-gp inhibitor 1 2050747-49-2 P-gp inhibitor 1 is a new inhibitor that can reverse P-glycoprotein-mediated multidrug resistance.
P-gp modulator 1 V31435 P-gp modulator 1 2249749-39-9 P-gp modulator 1 is a high-affinity, orally bioavailable modulator of p-glycoprotein (Pgp) that can reverse Pgp-mediated multidrug resistance.
P163-0892 V42009 P163-0892 1574576-45-6 P163-0892 is an antifungal with strong selectivity against Cryptococcus species.
P2X3拮抗剂34 V39602 P2X3 antagonist 34 2417288-67-4 P2X3 antagonist 34 is a potent, selective, orally bioactive P2X3 homotrimeric receptor blocker (antagonist) with IC50s of 25 nM, 92 nM and 126 nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively.
P300/CBP-IN-3 V31372 P300/CBP-IN-3 2299226-01-8 CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, compound 6, disclosed in patent WO 2019049061 A1.
p38-α MAPK-IN-1 V30528 p38-α MAPK-IN-1 443913-15-3 p38-α MAPK-IN-1 is an inhibitor (blocker/antagonist) of MAPK14 (p38-α) with IC50s of 2300 nM and 5500 nM in EFC and HTRF experiments, respectively.
p38α inhibitor 1 V34094 p38α inhibitor 1 1034189-82-6 p38α inhibitor 1 is an inhibitor (blocker/antagonist) of p38α, disclosed in patent WO 2008076265 A1.
p5 Ligand for Dnak and DnaJ V31761 p5 Ligand for Dnak and DnaJ 209518-24-1 p5 Ligand for Dnak and DnaJ is a nonapeptide that corresponds to the primary binding site in the 23-residue portion of the mitochondrial aspartate aminotransferase presequence.
p53 17-26 V30436 p53 17-26 488118-64-5 p53(17-26) is the 17 to 26 amino acid (AA) fragment of p53.
P62-mediated mitophagy inducer V32197 P62-mediated mitophagy inducer 1809031-84-2 P62-mediated mitophagy inducer (PMI) is a P62-mediated activator of mitosis.
PA (224-233), Influenza V31122 PA (224-233), Influenza 271573-27-4 PA (224-233), Influenza is a 10-amino acid (AA) polypeptide that is a fragment of the influenza A virus polymerase 2 protein.
Contact Us